Bibliographic Information

Advanced glycation end products in nephrology

Meeting on Advanced Glycosylation End Products in Nephrology: Much More Than Diabetic Nephropathy, January 14, 2000, Padua, Italy ; volume editors, Angela D'Angelo, Silvana Favaro, Giovanni Gambaro

(Contributions to nephrology, v. 131)

Karger, 2001

Search this Book/Journal
Note

Includes bibliographical references and indexes

Description and Table of Contents

Description

The pathological role of advanced glycation end products (AGEs) and of oxidative-carbonylic stress is well known in the context of diabetes. Moreover, there is also strong evidence that they play a pivotal role in the pathogenesis of some chronic disorders related to uremia, and namely to cardiovascular complications and dialysis-related amyloidosis. They may even play a crucial role in the loss of function of the peritoneal membrane in patients on peritoneal dialysis, a problem which limits the duration of such a treatment. Written by some of the most authoritative European experts, this publication includes up-to-date contributions on AGEs as related to diabetic nephropathy, hemodialysis and, particularly, peritoneal dialysis. The topics covered range from basic research (e.g. novel pathogenic pathways triggered by AGEs) to clinical issues, including substitutive therapy in uremic diabetic patients as well as original and new results from a clinical trial on peritoneal dialysis with a new bag. This publication will be of interest to nephrologists as well as those working in the field of diabetes or otherwise involved in AGE research, giving an idea into what direction research in this complex field is going and which will probably be the major clinical breakthroughs in the near future.

Table of Contents

  • Chemistry and pathobiology of advanced glycation end products, E.D. Schleicher et al
  • AGE in micro- and macroangiopathy, A. Lapolla et al
  • diabetic nephropathy and advanced glycation end products, P. Men et al
  • hemodialysis techniques and advanced glycation end products, N. Tessitore et al
  • diabetic uraemia and haemodialytic treatments, A. Naso, et al
  • peritoneal Dialysis in diabetic patients, M. Bertoli, et al
  • molecular biology of the peritoneal membrane - in between morphology and function, F. Anglani et al
  • peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs, M. Feriani
  • exogenous uptake of carbonyl stress compounds promoting AGE formation from peritoneal dialysis fluids, A. Wieslander et al
  • the dialytic failure of the peritoneal membrane, A. Lupo et al
  • a peritoneal dialysis solution prepared from a three-compartment bag - biological and clinical effects, G. Capelli et al
  • inhibition of transforming growth factor-b1 gene overexpression as a strategy to prevent fibrosis, G. Gambaro et al. Strategy for Preventing Peritoneal Dialysis Failure: Cancarini, G
  • clinical research in peritoneal dialysis, G.A. Coles
  • contribution of the mesangium to elastic strength and anchorage of the glomerular capillary tuft, R.B. Sterzel et al.

by "Nielsen BookData"

Related Books: 1-1 of 1
Details
Page Top